At P4A, we believe in striking an equilibrium in the orphan drug,
cell and gene therapy world. That means helping drive access to the
most appropriate treatments for patients and physicians, a fair return
on investment for manufacturers at an affordable proposition for payers
2015
P4A is established in Dec 2015 as a BV (Limited Company) in the Netherlands. Vertex becomes its first official customer.
Interesting fact: Vertex was a key inspiration in focusing solely on rare disease companies when founder, Sophie Schmitz, worked with the team supporting the original Kalydeco strategy.
2016
P4A sets up roots with a partnership in the US and establishes an office in London. P4A also supports its first gene therapy company develop their price and access strategy.
2017
P4A begins to firmly establish itself as an expert in gene therapy, presenting in various forums across the world at AMCP, WODC and several online events.
2018
P4A formalizes its Payer Expert Network supporting clients with informal and formal advice from payers across the world.
2019
XINTA, our analog intelligence engine is developed from our in-house expertise and knowledge.
2020
P4A wins Best Specialist Biotech Market Access Consultancy Award and continues to spread its roots throughout the EU, developing bases in Germany and Poland.
2021
Winners of Best Cell & Gene Therapy Global Market Access Consultancy; expanding MAXconnect into 3 arms: Rare Onco; Rare Non-Onco and ATMP specialisms. New and expanded London office opens.
2022
Continuing to win global awards in recognition of the innovative work we do supporting our clients on their commercial journeys from early development through to post launch.
2023
P4A create new RARE and CELL & GENE divisions to expand on the exceptional access work in these fields and launch new competitor intelligence service Gene-I.
2024
P4A launch a suite of digital solutions designed to speed-up access opportunities, and help clients understand the zeitgeist by harnessing the evolving power of A.I.
Our staff are carefully recruited and passionate about the Rare Disease world.
We are motivated by working in partnership with clients who share our vision
in creating and maintaining fair and sustainable healthcare systems for all stakeholders
Pride, passion and partnership are the core values at P4A. We
partner with our clients globally to achieve optimal patient access.
